{"acquisitions":[],"changes":[],"country":"FR","description":"TreeFrog Therapeutics develops cell therapies from iPS-derived 3D microtissues, with a lead program targeting Parkinson's disease. It serves patients with serious diseases who could benefit from regenerative cell therapy. Its C-Stem encapsulation platform enables billions of cells per batch for commercial-scale manufacturing.","domain":"treefrog.fr","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":44.8412,"lng":-0.5805,"location":"Bordeaux, France","multiples":[],"name":"TreeFrog Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2700000,"connectionsAmong":[],"currency":"EUR","date":"2025-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"treefrog-fr-2025-06-01-grant","source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"treefrog-fr","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"treefrog.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://treefrog.fr"},{"fact":"description","publisher":"treefrog.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://treefrog.fr"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["PHP 7.4","Lenis 1.1.13","Yoast SEO 24.9","YouTube","Google Analytics","Google Tag Manager","DoubleClick Floodlight","Contact Form 7 6.0.6","WPML 4.7.3","MySQL","wordpress ."],"totalRaisedUsd":82000000,"traction":[],"updatedAt":"2026-05-08","valuations":[]}